Table 1 Baseline characteristics of the participants in the EuroHYP-1 trial
Baseline characteristics | Intention-to-treat population | Per protocol population | ||
|---|---|---|---|---|
Intervention group | Control group | Intervention group | Control group | |
Centre | ||||
- name of centre 1, N (%) | ||||
- name of centre 2, N (%) | ||||
- name of centre 3, N (%) | ||||
- etc | ||||
Intention to perform thrombolysis, N (%) | ||||
Surface cooling, N (%) | ||||
Males, N (%) | ||||
Stroke severity (NIHSS), mean (SD), N | ||||
Age ≤ 65 years, N (%) | ||||
Age, mean (SD), N | ||||
Visible ischaemic lesion on brain imaging, N (%) | ||||
Time since symptom onset, N ≤ 4 hours (%) | ||||